RSS-Feed abonnieren
DOI: 10.1055/s-0030-1256331
© Georg Thieme Verlag KG Stuttgart · New York
Esophageal stents for benign refractory strictures: a meta-analysis
Publikationsverlauf
submitted 1 May 2010
accepted after revision 10 December 2010
Publikationsdatum:
24. März 2011 (online)
![](https://www.thieme-connect.de/media/endoscopy/201105/lookinside/thumbnails/10.1055-s-0030-1256331-1.jpg)
Background and aims: Fully covered self-expanding removable stents (SERS) have been considered a viable alternative to serial bougienage. The primary aim of this meta-analysis was to determine the efficacy of SERS for refractory esophageal strictures.
Methods: Medline, Embase, and PubMed databases were searched using the keywords ”esophageal stricture,” ”esophageal stents,” ”benign stricture,” ”dysphagia,” ”caustic,” ”peptic stricture,” ”anastomotic,” ”radiation,” and ”dysphagia” for the period from January 1965 to June 2010. Articles were selected for review independently by two authors (T. T. and J. M.) on the basis of predefined inclusion criteria, and the data collected. A meta-analysis using a random effects model was done.
Results: Eight studies with a total of 199 patients were included in the final analysis (104-males, average age 56 years, range: 49 – 68 years). Overall, 46.2 % of patients (95 %CI: 38.3 % – 54.1 %) had dysphagia improvement at an average follow up of 74 weeks. There was a significant difference (P = 0.019) in dysphagia improvement for patients with Polyflex stents (55.3 %; 95 %CI: 44.4 % – 65.9 %) versus nitinol stents (21.8 %; 95 %CI: 13.7 % – 33.7 %). On meta-regression, patient sex (P = 0.80), patient age (P = 0.725), corrosive etiology (P = 0.30), stricture location (P = 0.273), stricture length (P = 0.32), time of removal (P = 0.056), and duration of follow-up (0.35) had no significance influence on the outcome. The migration rate was 26.4 % (95 %CI: 25.3 % – 39.3 %).
Conclusions: Although the efficacy of SERS placement in benign refractory strictures is 46.2 %, it is associated with migration rate of 26.4 %. Nevertheless, the use of these temporary stents, which can be successfully removed in 87 % of patients, is an alluring prospect for treating patients with this difficult condition.
References
- 1 Kochman M L, McClave S A, Boyce H W. The refractory and the recurrent esophageal stricture: a definition. Gastrointest Endosc. 2005; 62 474-475
- 2 Siersema P D. Treatment options for esophageal strictures. Nat Clin Pract Gastroenterol Hepatol. 2008; 5 142-152
- 3 García-Cano J. Dilation of benign strictures in the esophagus and colon with the Polyflex stent: a case series study. Dig Dis Sci. 2008; 53 341-346
- 4 Barthel J S, Kelley S T, Klapman J B. Management of persistent gastroesophageal anastomotic strictures with removable self-expandable polyester silicon-covered (Polyflex) stents: an alternative to serial dilation. Gastrointest Endosc. 2008; 67 546-552
- 5 Stroup D F, Berlin J A, Morton S C et al. Meta-analysis of observational studies in epidemiology: proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000; 283 2008-2012
- 6 Elm D G, Egger M A, Pocock S J et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. For the STROBE Initiative. Bulletin of WHO. 2007; 85 867-872
- 7 Thompson S G, Sharp S J. Explaining heterogeneity in meta-analysis. Stat Med. 1999; 18 2693-2708
- 8 DerSimonian R, Laird L. Meta-analysis in clinical trials. Control Clin Trials. 1986; 7 177-188
- 9 Sharp S J. Meta analysis regression. Stata Tech Bull. 1998; 42 16-22
- 10 Sutton A J, Abrams K R, Jones D R et al. Methods for meta-analysis in medical research.. Chichester: Wiley; 2000
- 11 Kim H J, Song Y H, Choi K E et al. Temporary metallic stent placement in the treatment of refractory benign esophageal strictures: results and factors associated with outcome in 55 patients. Eur Radiol. 2009; 19 384-390
- 12 Dua S K, Vleggaar P F, Santharam R, Siersema P D. Removable self-expanding plastic esophageal stent as a continuous, non-permanent dilator in treating refractory benign esophageal strictures: a prospective two-center study. Am J Gastroenterology. 2008; 103 2988-2994
- 13 Martin C JR, Woodall C, Duvall R et al. The use of self-expanding silicone stents in esophagectomy strictures: less cost and more efficiency. Ann Thorac Surg. 2008; 86 436-440
- 14 Karbowski M, Scembre D, Kozarek R et al. Polyflex self-expanding, removable plastic stents: assessment of treatment efficacy and safety in a variety of benign and malignant conditions of the esophagus. Surg Endos. 2008; 22 1326-1333
- 15 Oh Y S, Kochman M L, Ahmed N A et al. Clinical outcomes after self expanding plastic stent placement for benign refractory strictures. Dig Dis Sci. 2010; 55 1344-1348
- 16 Evrard S, Moine L O, Lazaraki G et al. Self-expanding plastic stents for benign esophageal lesions. Gastrointest Endosc. 2004; 60 894-900
- 17 Repici A, Conio M, Angelis C et al. Temporary placement of an expandable polyester silicone-covered stent for treatment of refractory benign esophageal strictures. Gastrointest Endosc. 2004; 60 513-519
- 18 Song H o-Y, Jung H, Park S et al. Covered retrievable expandable nitinol stents in patients with benign esophageal strictures: initial experience. Radiology. 2000; 217 551-557
- 19 Ferguson D D. Evaluation and management of benign esophageal strictures. Dis Esophagus. 2005; 18 359-364
- 20 Spechler S J. AGA technical review on treatment of patients with dysphagia caused by benign disorders of the distal esophagus. Gastroenterology. 1999; 117 233-254
- 21 Shah J N. Benign refractory esophageal strictures: widening the endoscopist’s role. Gastrointest Endosc. 2006; 63 164-167
- 22 Wadhwa R P, Kozareck R, France R et al. Use of self expandable metal stent in benign oesophageal disease. Gastrointest Endosc. 2003; 58 207-212
- 23 Knezevic J D, Radovanovic N S, Simic A P et al. Colonic interposition in the treatment of esophageal caustic strictures: 40 years of experience. Dis Esophagus. 2007; 20 530-534
- 24 Cheng Y S, Yang R J, Shang K Z et al. Esophageal benign stricture with temporary stent insertion. Jie Ru Fang She Xue Za Zhi. 1999; 8 32-34
- 25 Siersema P D, Hirdes M M. What is the optimal duration of stent placement for refractory, benign esophageal strictures?. Nat Clin Pract Gastroenterol Hepatol. 2009; 6 146-147
- 26 Kim J H, Song H Y, Kim H C et al. Corrosive oesophageal strictures: long term effectiveness of balloon dilation in 117 patients. J Vasc Interv Radiol. 2008; 19 736-741
- 27 Altintas E, Kacar S, Tunc B et al. Intralesional steroid injection in benign esophageal strictures resistant to bougie dilation. J Gastroenterol Hepatol. 2004; 19 1388-1391
- 28 Holm A N, Levy M, Gostout J C et al. Self-expanding plastic stents in treatment of benign esophageal conditions. Gastrointest Endosc. 2008; 67 20-25
- 29 Repici A, Vleggaar P F, Carlino A et al. Benign refractory esophageal strictures: preliminary results from the BEST (Biodegradable Esophageal STents) study [abstract]. Gastrointest Endosc. 2009; 69 AB22
- 30 Siersema P D, de Wijkerslooth L R. Dilation of refractory benign strictures. Gastrointest Endosc. 2009; 70 1000-1012
K. RagunathMD, FRCP (Lond)
Nottingham Digestive Diseases Centre and NIHR Biomedical Research Unit
Queens Medical Centre Campus
Derby Road
Nottingham
NG27 2UH
United Kingdom
eMail: k.ragunath@nottingham.ac.uk